PRP guidelines · International

Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial

Adam W Anz, Ryan Hubbard, Nicole K Rendos, Peter A Everts, James R Andrews, Joshua G Hackel

Orthopaedic Journal of Sports Medicine · 2020

In brief

A randomised trial compared one injection of bone marrow aspirate concentrate (BMAC) with leukocyte-rich platelet-rich plasma (PRP) in mild to moderate knee osteoarthritis over about a year. Both groups improved in pain and function and neither was superior. The authors note PRP has stronger supporting evidence and that the lack of a control group may have influenced results.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial Authors: Adam W Anz, Ryan Hubbard, Nicole K Rendos, Peter A Everts, James R Andrews, Joshua G Hackel Link: https://pubmed.ncbi.nlm.nih.gov/32118081/ Year of Publication: 2020

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.